| IL-4/IL-13 stimulated macrophages enhance breast cancer invasion via rho-GTPase regulation of synergistic VEGF/CCL-18 signaling AC Little, P Pathanjeli, Z Wu, L Bao, LE Goo, JA Yates, CR Oliver, ... Frontiers in Oncology 9, 456, 2019 | 92 | 2019 |
| High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions AC Little, I Kovalenko, LE Goo, HS Hong, SA Kerk, JA Yates, V Purohit, ... Communications biology 3 (1), 271, 2020 | 75 | 2020 |
| Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8 JA Yates, T Menon, BA Thompson, DA Bochar FEBS letters 584 (4), 689-693, 2010 | 62 | 2010 |
| Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8 T Menon, JA Yates, DA Bochar Molecular endocrinology 24 (6), 1165-1174, 2010 | 60 | 2010 |
| BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program DH Kim, D Sun, WK Storck, K Welker Leng, C Jenkins, DJ Coleman, ... Clinical Cancer Research 27 (17), 4923-4936, 2021 | 55 | 2021 |
| A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche CR Oliver, MA Altemus, TM Westerhof, H Cheriyan, X Cheng, ... Lab on a Chip 19 (7), 1162-1173, 2019 | 52 | 2019 |
| Macrophages enhance migration in inflammatory breast cancer cells via RhoC GTPase signaling SG Allen, YC Chen, JM Madden, CL Fournier, MA Altemus, AB Hiziroglu, ... Scientific reports 6 (1), 39190, 2016 | 51 | 2016 |
| Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer A Kumaraswamy, KRW Leng, TC Westbrook, JA Yates, SG Zhao, ... European urology 80 (1), 71-81, 2021 | 49 | 2021 |
| Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes MA Altemus, LE Goo, AC Little, JA Yates, HG Cheriyan, ZF Wu, ... PloS one 14 (9), e0220973, 2019 | 49 | 2019 |
| Loss of PTEN promotes formation of signaling-capable clathrin-coated pits LK Rosselli-Murai, JA Yates, S Yoshida, J Bourg, KKY Ho, M White, ... Journal of cell science 131 (8), jcs208926, 2018 | 40 | 2018 |
| RhoC GTPase is a potent regulator of glutamine metabolism and N-acetylaspartate production in inflammatory breast cancer cells ML Wynn, JA Yates, CR Evans, LD Van Wassenhove, ZF Wu, S Bridges, ... Journal of Biological Chemistry 291 (26), 13715-13729, 2016 | 38 | 2016 |
| Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity TC Westbrook, X Guan, E Rodansky, D Flores, CJ Liu, AM Udager, ... Nature communications 13 (1), 5345, 2022 | 26 | 2022 |
| Alternative splicing of LSD1+ 8a in neuroendocrine prostate cancer is mediated by SRRM4 DJ Coleman, DA Sampson, A Sehrawat, A Kumaraswamy, D Sun, ... Neoplasia 22 (6), 253-262, 2020 | 25 | 2020 |
| The role of epigenetic change in therapy-induced neuroendocrine prostate cancer lineage plasticity WK Storck, AM May, TC Westbrook, Z Duan, C Morrissey, JA Yates, ... Frontiers in Endocrinology 13, 926585, 2022 | 19 | 2022 |
| Norstictic acid is a selective allosteric transcriptional regulator JM Garlick, SM Sturlis, PA Bruno, JA Yates, AL Peiffer, Y Liu, L Goo, ... Journal of the American Chemical Society 143 (25), 9297-9302, 2021 | 17 | 2021 |
| Identification and characterization of sea squirt telomerase reverse transcriptase Y Li, JA Yates, JJL Chen Gene 400 (1-2), 16-24, 2007 | 16 | 2007 |
| LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function A Kumaraswamy, Z Duan, D Flores, C Zhang, A Sehrawat, YM Hu, ... JCI insight 8 (15), 2023 | 11 | 2023 |
| Molecular determinants of drug response in TNBC cell lines NM Merrill, EJ Lachacz, NM Vandecan, PJ Ulintz, L Bao, JP Lloyd, ... Breast cancer research and treatment 179, 337-347, 2020 | 10 | 2020 |
| Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis TM Westerhof, BA Yang, NM Merrill, JA Yates, M Altemus, L Russell, ... Advanced nanobiomed research 3 (4), 2200036, 2023 | 4 | 2023 |
| RhoC modulates cell junctions and Type I interferon response in aggressive breast cancers HG Abraham, PJ Ulintz, L Goo, JA Yates, AC Little, L Bao, Z Wu, ... Frontiers in Oncology 11, 712041, 2021 | 3 | 2021 |
Sofia D. Merajver, MD, PhDProfessor of Internal Medicine and Epidemiology, University of Michigan在 umich.edu 的电子邮件经过验证
